Format
Sort by

Send to:

Choose Destination

Results: 5

Related Articles by Review for PubMed (Select 15331175)

1.

MPO and SOD2 polymorphisms, gender, and the risk of non-small cell lung carcinoma.

Liu G, Zhou W, Wang LI, Park S, Miller DP, Xu LL, Wain JC, Lynch TJ, Su L, Christiani DC.

Cancer Lett. 2004 Oct 8;214(1):69-79.

PMID:
15331175
2.

No association between SOD2 Val16Ala polymorphism and breast cancer susceptibility: a meta-analysis based on 9,710 cases and 11,041 controls.

Ma X, Chen C, Xiong H, Fan J, Li Y, Lin H, Xu R, Huang G, Xu B.

Breast Cancer Res Treat. 2010 Jul;122(2):509-14. doi: 10.1007/s10549-009-0725-2. Epub 2010 Jan 6. Review.

PMID:
20052533
3.

Association between manganese superoxide dismutase (MnSOD) Val-9Ala polymorphism and cancer risk - A meta-analysis.

Wang S, Wang F, Shi X, Dai J, Peng Y, Guo X, Wang X, Shen H, Hu Z.

Eur J Cancer. 2009 Nov;45(16):2874-81. doi: 10.1016/j.ejca.2009.04.024. Epub 2009 May 19. Review.

PMID:
19467856
4.

Myeloperoxidase promoter region polymorphism and lung cancer risk.

Wu X, Schabath MB, Spitz MR.

Methods Mol Med. 2003;75:121-33. Review.

PMID:
12407737
5.

Relationships between single nucleotide polymorphisms of antioxidant enzymes and disease.

Crawford A, Fassett RG, Geraghty DP, Kunde DA, Ball MJ, Robertson IK, Coombes JS.

Gene. 2012 Jun 15;501(2):89-103. doi: 10.1016/j.gene.2012.04.011. Epub 2012 Apr 14. Review.

PMID:
22525041
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk